Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transforming growth factor beta 1 genotype and p16 as prognostic factors in head and neck squamous cell carcinoma.

Acta oto-laryngologica - 1 Sept 2012

Lundberg Marie, Leivo Ilmo, Saarilahti Kauko, Mäkitie Antti A, Mattila Petri S

Abstract excerpt

CONCLUSION: Transforming growth factor β1 gene (TGFβ1) genotype is a potential p16 independent prognostic factor predicting response to chemoradiotherapy in head and neck squamous cell carcinoma (HNSCC). OBJECTIVES: Expression of p16 and epidermal growth factor receptor (EGFR) has been reported to be associated with survival in HNSCC. We have previously reported that genetic polymorphism of TGFβ1 is linked with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Squamous Cell
Share to Cyclin-Dependent Kinase Inhibitor p16

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to ErbB Receptors

Share to Follow-Up Studies

Share to Gene Expression Regulation, Neoplastic

Share to Prognosis

Share to Transforming Growth Factor beta1

Source

Identifiers

PMID: 22667340
DOI: 10.3109/00016489.2012.678944

Genes

EGFR
TGFB1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transforming growth factor beta 1 genotype and p16 as prognostic factors in head and neck squamous cell carcinoma.PMID 22667340Read ↗

TGFβ1 Genetic Variants Predict Clinical Outcomes of HPV-Positive Oropharyngeal Cancer Patients after Definitive Radiotherapy.Semantic proximity Read ↗

Association between transforming growth factor beta1 genetic polymorphism and response to chemoradiotherapy in head and neck squamous cell cancer.Semantic proximity Read ↗

Prognostic value of transforming growth factor beta receptor 1 polymorphisms in patients with oral cancer.Semantic proximity Read ↗

ATM, BCL2, and TGFβ Gene Polymorphisms as Radiotherapy Outcome Biomarkers in Head and Neck Squamous Cell Carcinoma Patients.Semantic proximity Read ↗

Protective role of TGF-β1 (-509C>T, rs1800469) single-nucleotide polymorphism against radiation toxicities in locally advanced head and neck cancer.Semantic proximity Read ↗

Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancer.Semantic proximity Read ↗

TGFbeta1 genetic polymorphism is associated with survival in head and neck squamous cell carcinoma independent of the severity of chemoradiotherapy induced mucositis.Semantic proximity Read ↗

Genetic variations in the transforming growth factor-beta pathway as predictors of survival in advanced non-small cell lung cancer.Semantic proximity Read ↗

p16 and p53 Protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer.Semantic proximity Read ↗

TGFβ1 Polymorphisms Predict Distant Metastasis-Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy.Semantic proximity Read ↗

HPV genotypes predict survival benefits from concurrent chemotherapy and radiation therapy in advanced squamous cell carcinoma of the cervix.Semantic proximity Read ↗

A putatively functional haplotype in the gene encoding transforming growth factor beta-1 as a potential biomarker for radiosensitivity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.